New procedures and policies for the electronic Certificate of Pharmaceutical Product (eCPP)
3 October 2022
13:00 - 15:00
This event has now passed. To browse our upcoming events click here.
This webinar provided a platform for discussion of new policies, procedures, and trends in use of electronic Certificate of Pharmaceutical Product (eCPP), to support regulators worldwide to adapt their national procedures to streamline the use of eCPP, when applicable.
This exchange of information is beneficial to both regulators and companies, representing a clear area of cooperation between different stakeholders.
With the participation of WHO and global regulators, the webinar touched upon the benefits of using eCPP through practical examples from EU, Egypt and other regions and potential solutions for an effective implementation.
Regulators, industry representatives in Africa, Asia, Middle East, Latin America and the Caribbean.
Presentations followed by Q&A panel discussion with regulators and the audience.
Interpretation offered in French, Portuguese and Spanish.
Welcome and presentation of objectives of the webinarby Nevena Miletic (Roche), IFPMA Chair of CPP Network and Jyothsna Krishnan – Director, Regulatory Drug development & manufacturing at EFPIA.
- WHO’s recommendation for the use of eCPP – Samvel Azatyan – Team Lead, Regulatory Convergence and Networks at World Health Organization
- EMA’s practices and policies for issuing eCPP – Alberto Ganan Jimenez – Head of Procedures Office, Committees and Quality Assurance Department, European Medicines Agency (EMA)
- EDA’s lessons from the use of eCPPs – Maryam Ali Abdelmoneim – Egyptian Drug Authority, Box Inquiry Unit Manager in Administration of Registration
Panel discussion Q&A with representatives from WHO, EDA, EMA, MHRA
Final remarks by Patricia Salami – PhRMA MEA RA Group Chair (Merck KGaA)